schönes Vol. leider wird das aber abverkauft, da noch das ATM-Programm läuft und KE wird bestimmt kommen.
schöne Gewinne bis jetzt sind es trotzdem, glückwunsch an alle :-)
alles aussem Annual Report
We have no assurances that we will be able to raise additional funds through the sale of our common shares, consequently, we will continue to evaluate all types of financing arrangements. In an effort to be able to evaluate all types of financing arrangements, we maintain a current short form base shelf prospectus (the Base Shelf) that qualifies for distribution of up to $150,000,000 of common shares, subscription receipts, warrants, or units (the Securities)
On February 25, 2016, we entered into a new ATM equity distribution agreement with Canaccord Genuity Inc. acting as our sole agent with an aggregate offering value of up to $4.6 million.........
During 2016, we sold 3,006,600 common shares for gross proceeds of $1,456,296.
www.oncolyticsbiotech.com/wp-content/..._Annual_Report_web.pdf
